ArticleBMJ open2024

Multicentre, open-label, randomised, controlled trial to compare early intervention with calcimimetics and conventional therapy in preventing coronary artery calcification in patients with secondary hyperparathyroidism (UPCOMING): a study protocol.

Daijo Inaguma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.